2015
DOI: 10.1080/10503307.2015.1110635
|View full text |Cite
|
Sign up to set email alerts
|

The shorter the better? A follow-up analysis of 10-session psychiatric treatment including the motive-oriented therapeutic relationship for borderline personality disorder

Abstract: These results are overall consistent with earlier studies on short-term treatments for BPD and underline the importance of individualizing interventions, by using case formulations that rely on idiographic methods and integrative concepts.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 17 publications
(9 citation statements)
references
References 25 publications
(36 reference statements)
0
9
0
Order By: Relevance
“…Finally, Pearson's partial correlations were conducted between delta MAS‐R and symptom change during the 6‐month follow‐up (OQ‐45 score at 6‐month follow‐up – OQ‐45 score at discharge), controlling for MAS‐R score at intake and OQ‐45 score at discharge. Analyses were made on n = 20 participants (eight were part of the GPM group and 12 of the GPM + MOTR group), due to missing values at follow‐up (Kramer, Stulz, et al ., ). A negative correlation was found between delta MAS‐R and delta OQ‐45: r = −.403, p = .049, suggesting that the greater the MAS‐R improvement during treatment, the greater the symptom reduction during follow‐up.…”
Section: Resultsmentioning
confidence: 97%
See 2 more Smart Citations
“…Finally, Pearson's partial correlations were conducted between delta MAS‐R and symptom change during the 6‐month follow‐up (OQ‐45 score at 6‐month follow‐up – OQ‐45 score at discharge), controlling for MAS‐R score at intake and OQ‐45 score at discharge. Analyses were made on n = 20 participants (eight were part of the GPM group and 12 of the GPM + MOTR group), due to missing values at follow‐up (Kramer, Stulz, et al ., ). A negative correlation was found between delta MAS‐R and delta OQ‐45: r = −.403, p = .049, suggesting that the greater the MAS‐R improvement during treatment, the greater the symptom reduction during follow‐up.…”
Section: Resultsmentioning
confidence: 97%
“…The present study represents a secondary process‐outcome analysis based on a RCT (Kramer et al ., , N = 85), using a subsample of a process‐outcome mediation analysis (Kramer, Stulz, et al ., ; N = 57). The study was offered to each adult (between 18 and 65 years of age) addressed to a specialized centre for borderline personality disorder ( BPD ), which was part of an outpatient university psychiatric clinic.…”
Section: Methodsmentioning
confidence: 97%
See 1 more Smart Citation
“…The treatment followed a manual (Kolly, Kramer, Herrera, Follonier, Maksutaj, Schopfer et al, 2010) which was adapted from the Good Psychiatric Management (GPM; Gunderson & Links, 2014). GPM has shown in earlier studies to be an effective generalist treatment, both for the long-term treatment (McMain, Links, Gnam, Guimond, Cardish, Korman et al, 2009) and in the short-term treatment within a stepped-care approach (Kramer, Kolly, Berthoud, Keller, Preisig, Caspar et al, 2014;Kramer, Stulz, Berthoud, Caspar, Marquet, Kolly et al, 2017). The treatment encompassed the establishment of a psychiatric diagnosis, the development of a treatment focus and discussion of major symptoms and interpersonally relevant situations.…”
Section: Participantsmentioning
confidence: 99%
“…MOTR is not a distinct treatment form, but a set of therapeutic principles, which determine how to best build a therapeutic relationship and conduct therapeutic interventions, and can be added to any (pharmacological or psychosocial) treatment form . While MOTR has been a demonstrated utility in the treatment of affective disorders (Caspar, Grossmann, Unmuessig, & Schramm, 2005;Kramer, Berger, & Caspar, 2009;Kramer, Rosciano, et al, 2011), post-traumatic stress disorder (Kramer, 2009), and personality disorders (Caspar & Ecker, 2008;Kramer, Berger, et al, 2011;Kramer, Caspar, & Drapeau, 2013;Kramer, Fluckiger, et al, 2014;Kramer et al, 2015), it has not been examined in the treatment of psychosis so far.…”
Section: Introductionmentioning
confidence: 99%